Yesterday
Are you overweight or obese? Depends on where you carry your fat
European experts have developed a new framework to modernise the staging, diagnosis and management of obesity.
- Jill Margo
Forced smiles: Crescent Capital, Genesis get their fangs out
Pacific Smiles has been in a holding pattern since the dispute broke out.
- Sarah Thompson, Kanika Sood and Emma Rapaport
This Month
I-MED snaps up US teleradiology player StatRad
Aussie imaging giant I-MED is hoping to recreate its fast-growing teleradiology business in the US with a major acquisition.
- Tess Bennett
- Exclusive
- Venture capital
Frazis unveils venture capital fund, makes first investments
The Gen Y tech investor has nabbed stakes in a dozen start-ups in tech, health and e-commerce, thanks to $10 million raised from wealthy investors.
- Tom Richardson
June
Why people with cancer don’t get the full benefit of clinical trials
Australian researchers say regulators should mandate the requirement to share data.
- Jill Margo
- Exclusive
- Industrial relations
Nurses identify ‘$1.2bn’ in savings for 15 per cent pay rise
Deloitte’s report for the NSW nurses’ union found the state government may have missed out on more than $3 billion in Commonwealth funding due to inaccurate data.
- David Marin-Guzman
Radiology’s AI future and deregulation help end years of bad blood
The No.1 player in an industry sets the tone. And in radiology, the tone is deals, deals, deals.
- Anthony Macdonald
Integral Diagnostics dealmaking creates $1b diagnostics giant
The company has proposed a merger with its smaller rival, Capitol Health, creating the largest pure-play diagnostics imaging group on the ASX.
- Kylar Loussikian
- Opinion
- Hospitals
The bottom line is private hospitals are evolving, not collapsing
The government’s “financial health check” review should kick-start a conversation about innovation and the fate of some old, inefficient facilities.
- Matthew Koce
Telix pulls $300m Nasdaq IPO as investors demand deep discount
The cancer treatment hopeful had announced plans to list in New York only last week as it searched for more capital. On Friday, it withdrew from the initial public offering.
- Kylar Loussikian
- Exclusive
- Mark Butler
Private hospitals open books for urgent ‘health check’
Health Minister Mark Butler has launched an urgent review into the $22 billion private hospital system.
- Tom McIlroy
Inside Chemist Warehouse’s $600m money spinner
It has nothing to do with medicine. Instead, its advertising business – retail media – spans everything from an in-house ad agency to television and radio.
- Carrie LaFrenz and Sam Buckingham-Jones
Cryogenic start-up focuses on thawing the frozen waiting for a cure
A former child prodigy is working on ways to ensure that bodies can be revived when the time is right.
- Ashlee Vance
Sonic Healthcare-backed Harrison.ai boots up $100m-plus Series C raise
Harrison.ai’s management team has commenced discussions with a handful of potential investors regarding the cash call.
- Sarah Thompson, Kanika Sood and Emma Rapaport
TPG hires industry heavy hitters for $1.5b fund; eyes 3.2-times money
Former Telstra chief executive Andy Penn has signed up to lead the $1.5 billion TPG Emerging Companies Asia Fund’s efforts in new economy and cyber sectors.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Qualitas Health doctors in management buyout talks; $250m deal tipped
Qualitas’ doctor-shareholders went through a few rounds of talks with Michael Alscher’s healthcare-focused Crescent Capital Partners but failed to agree on terms.
- Sarah Thompson, Kanika Sood and Emma Rapaport
- Exclusive
- Cancer
GenesisCare’s valuation shrinks to less than $500m after bankruptcy
Once a global cancer services giant, the company’s new owners are buying back shares from local backers for just $0.000186 as the business is restructured.
- Carrie LaFrenz
Crescent Capital set to take radiology business off The Growth Fund
Crescent Capital, which claims to be the country’s most active private equity manager in healthcare, has secured exclusivity.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Immutep raises $100m and signs with Merck on ‘blockbuster’ drug
Shares in the oncology therapy hopeful have risen some 45 per cent in the last 12 months as the company nears the commercialisation of its drug, Efti.
- Kylar Loussikian
May
Fisher & Paykel leaves pandemic behind as respirator demand grows
Earlier this year, Vertium Asset Management’s Jason Teh put the New Zealand-based group on his list of turnaround prospects. Issues at its rival are helping.
- Kylar Loussikian